← Back to All Filings

Omega Healthcare CIO Awarded Grant Equaling 6.4% of Outstanding Shares

High SignificanceJanuary 15, 2026 at 11:32:00 PM UTC

OMEGA HEALTHCARE INVESTORS INC

$OHI4CIK: 0000888491

Subscribe to track OHI

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Omega Healthcare CIO Awarded Grant Equaling 6.4% of Outstanding Shares

Company: OMEGA HEALTHCARE INVESTORS INC (OHI) Form: 4 | Filed: 2026/01/15 Significance: High

Insider: Gupta Vikas Title: Chief Investment Officer | Relationship: Officer

Transaction: • Type: Grant • Shares: 18,898 • Price: $0.00 • Value: $0 • Owned After: 133,064 units

Key Insight: The Chief Investment Officer received an equity grant representing a substantial 6.41% of the company's total shares outstanding, a highly material event indicating significant potential future dilution.

Market Context: This grant significantly increases the CIO's potential ownership stake to over 45% of the company, based on the provided market data. The size of the grant relative to the share count is exceptionally large.

Comprehensive Analysis

SEC Filing Analysis: OMEGA HEALTHCARE INVESTORS INC (OHI)

Executive Summary

  • Trading Significance: High
  • Key Takeaway: The Chief Investment Officer was awarded an equity grant of Profits Interest Units equivalent to 18,898 shares, representing a massive 6.41% of the company's total shares outstanding.
  • Market Impact: While a non-market transaction, the sheer size of the grant signals a highly material potential dilution event for existing shareholders upon vesting.

Company Information

FieldValue
CompanyOMEGA HEALTHCARE INVESTORS INC
Ticker SymbolOHI
CIK0000888491
IndustryREAL ESTATE INVESTMENT TRUSTS

Insider Information

FieldValue
NameGupta Vikas
CIK0002051514
Title/PositionChief Investment Officer
RelationshipOfficer

Transaction Details

FieldValue
Form Type4
Transaction Date2026-01-13
Transaction CodeA (Grant)
Security TypeProfits Interest Units
Shares Involved18,898
Price Per Share$0.00
Total Value$0
Shares Owned After133,064
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$0
% of Market Cap0.00%
Shares Transacted18,898
% of Shares Outstanding6.41%
Post-Transaction Ownership133,064 units (45.11% of outstanding)
Materiality AssessmentHighly Significant

Impact Evaluation

  • Market Cap Context: For a $12.99 billion company, the grant's significance is not in its $0 value but in its dilutive power. An equity award of this magnitude is unusual.
  • Ownership Concentration: Post-grant, the CIO's potential ownership of 133,064 units represents a staggering 45.11% of the 295,000 shares outstanding provided in the market data. This level of concentration in a single non-founder executive is extremely high and a critical factor for investors.
  • Dilution Impact: The grant of 18,898 units represents a potential 6.41% dilution to existing shareholders upon vesting and conversion. This is a highly material level of dilution from a single compensation event. Note: The provided shares outstanding figure of 295,000 for a $12.99B company appears anomalous and significantly amplifies the calculated percentages. The analysis is based on the data provided.
  • Transaction Significance: The significance is HIGH, driven entirely by the shares transacted as a percentage of shares outstanding (6.41%), which far exceeds the 0.5% threshold for high significance.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: This is a scheduled compensation award, not a discretionary market transaction reflecting insider sentiment. The primary impact is the long-term potential for share dilution, not an immediate signal about the company's near-term prospects.

Volume & Sentiment

  • Expected Volume Impact: None. This transaction did not occur on the open market.
  • Sentiment Indicator: Neutral. While the size of the grant is notable and could raise questions about compensation strategy, equity awards are a standard practice.

Investment Insights

Positive Market Indicators

  • The award is structured to align the CIO's long-term interests with shareholders, as the units only become valuable upon vesting and conversion.

Risk Factors

  • Extreme Dilution: A 6.41% potential dilution from a single grant to one executive is a major risk for current shareholders.
  • Ownership Concentration: The CIO's potential ownership stake of 45.11% is exceptionally high and could give one executive significant influence.
  • Compensation Scrutiny: The size of the grant may attract scrutiny regarding the company's executive compensation practices.

Key Takeaways

  1. The CIO received a highly significant equity grant relative to the company's total shares outstanding.
  2. The transaction signals a potential dilution of 6.41% to existing shareholders, a material event.
  3. The CIO's potential ownership stake has increased to a commanding 45.11% of the company, based on the provided data.

Additional Context

Transaction Notes

  • The securities are Profits Interest Units (PIUs) which are convertible into common stock on a one-for-one basis after vesting.
  • The grant has a three-year cliff vesting schedule, ending on December 31, 2028, incentivizing long-term performance.
Topics:#OmegaHealthcare#OHI#InsiderTrading#Form4#SECFiling#EquityGrant#HighSignificance#CIO#REIT#StockMarket

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is AI-generated from public SEC filings and may contain errors. It is for informational and educational purposes only and is not investment, legal, or tax advice.

The Filing Fool is not a registered investment adviser, broker-dealer, or financial planner. Nothing here is a recommendation or solicitation to buy, sell, or hold any security.

Always do your own due diligence and consult a licensed professional.